Upstream Biotechnology develops broad-spectrum disease resistant crops using patented technologies.
Upstream Biotechnology has raised $625K in total funding. The most recent round was Seed. The last funding was announced in July 2026.
Upstream Biotechnology's investors include LeVert Ventures, Corteva Catalyst, VTC Ventures, Silver Blue.
Upstream Biotechnology is headquartered in Chapel Hill, United States.
Upstream Biotechnology develops broad-spectrum disease resistant crops using patented technologies.
Upstream Biotechnology is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Upstream Biotechnology — Funding & Investors." VCBacked, July 30, 2026, https://www.vcbacked.co/company/upstream-biotechnology. Accessed August 13, 2026.
VCBacked. (2026). Upstream Biotechnology — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/upstream-biotechnology
{{cite web |title=Upstream Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/upstream-biotechnology |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated